FGF2 and neoplasm: The use of BFGF-modified OMVs (BFGF-OMVs) as an antitumor vaccine can induce high levels of anti-BFGF autoantibodies, which can inhibit angiogenesis, promote tumor cell apoptosis, and reverse tumor immunosuppression [55].